[{"Assets_0_Q2_USD":416164000.0,"CommonStockSharesOutstanding_0_Q2_shares":46854762.0,"EarningsPerShareBasic_2_Q2_USD":-0.46,"EarningsPerShareBasic_1_Q2_USD":-0.15,"EarningsPerShareDiluted_2_Q2_USD":-0.46,"EarningsPerShareDiluted_1_Q2_USD":-0.15,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-23508000.0,"NetIncomeLoss_2_Q2_USD":-21519000.0,"NetIncomeLoss_1_Q2_USD":-6885000.0,"StockholdersEquity_0_Q2_USD":301365000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":46683744.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":46767759.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":46683744.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":46767759.0,"Ticker":"XNCR","CIK":"1326732","name":"XENCOR INC","OfficialName":"Xencor Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574633486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170807"}]